NGHLF
Nightingale Health Oyj
Price Chart
Latest Quote
$1.19
| Previous Close | $1.19 |
| Open | $1.19 |
| Day High | $1.19 |
| Day Low | $1.19 |
| Volume | 100 |
Stock Information
| Shares Outstanding | 40.54M |
| Total Debt | $5.55M |
| Cash Equivalents | $48.68M |
| Revenue | $5.45M |
| Net Income | $-21.69M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $71.83M |
| EPS (TTM) | $-0.37 |
| Exchange | OQX |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $33.90M |
| Sales | $5.45M |
| Income | $-21.69M |
| Book/sh | $1.10 |
| Cash/sh | $1.06 |
| Employees | 103 |
Financial Ratios
| Quick Ratio | 8.19 |
| Current Ratio | 8.53 |
| Debt/Eq | 8.42 |
Returns & Margins
| ROA | -16.07% |
| ROE | -28.54% |
| Gross Margin | 67.36% |
| Operating Margin | -363.78% |
Ownership
| Insider Ownership | 33.66% |
| Institutional Ownership | 8.51% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 14.98 |
| P/B | 1.08 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.19 |
| SMA50 | $1.37 |
| SMA200 | $1.65 |
| RSI | nan |
| Shares Float | 29.25M |
| Volatility | 0.32 |
| Rel Volume | 20.00 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | -32.00% |
| 6 Months | -32.00% |
| YTD | -32.00% |
| Year | -32.00% |
| 10 Years | -32.00% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $1.19 | 100 |
| 2026-06-22 | $1.19 | 0 |
| 2026-06-18 | $1.19 | 0 |
| 2026-06-17 | $1.19 | 0 |
| 2026-06-16 | $1.19 | 0 |
| 2026-06-15 | $1.19 | 0 |
| 2026-06-12 | $1.19 | 0 |
| 2026-06-11 | $1.19 | 0 |
| 2026-06-10 | $1.19 | 0 |
| 2026-06-09 | $1.19 | 0 |
| 2026-06-08 | $1.19 | 0 |
| 2026-06-05 | $1.19 | 0 |
| 2026-06-04 | $1.19 | 0 |
| 2026-06-03 | $1.19 | 0 |
| 2026-06-02 | $1.19 | 0 |
| 2026-06-01 | $1.19 | 0 |
| 2026-05-29 | $1.19 | 0 |
| 2026-05-28 | $1.19 | 0 |
| 2026-05-27 | $1.19 | 0 |
| 2026-05-26 | $1.19 | 0 |
About Nightingale Health Oyj
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
đ° Latest News
European Penny Stocks With Market Caps Under âŦ50M To Consider
Simply Wall St. âĸ 2026-06-02T11:05:05ZEuropean Penny Stocks: 3 Picks Below âŦ200M Market Cap
Simply Wall St. âĸ 2026-02-13T06:04:52ZEuropean Opportunities: 3 Penny Stocks With Market Caps Under âŦ100M
Simply Wall St. âĸ 2025-12-15T11:04:57ZNovember 2025's European Penny Stocks Worth Watching
Simply Wall St. âĸ 2025-11-05T06:11:59ZLhyfe And 2 Other European Penny Stocks To Enhance Your Portfolio
Simply Wall St. âĸ 2025-09-23T06:06:06ZDiscovering European Penny Stocks In August 2025
Simply Wall St. âĸ 2025-08-25T06:08:45ZEuropean Penny Stocks To Consider In July 2025
Simply Wall St. âĸ 2025-07-08T06:05:05ZIncome Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,155,000 | $1,462,000 | $590,000 | $1,037,000 |
| Cost Of Revenue | $1,155,000 | $1,462,000 | $590,000 | $1,037,000 |
| Total Revenue | $4,693,000 | $4,358,000 | $4,182,000 | $2,313,000 |
| Operating Revenue | $4,693,000 | $4,358,000 | $4,182,000 | $2,313,000 |
| Expenses | ||||
| Interest Expense | $1,289,000 | $798,000 | $2,000 | $767,000 |
| Total Expenses | $24,096,000 | $23,000,000 | $22,879,000 | $15,967,000 |
| Other Non Operating Income Expenses | $23,000 | $83,000 | $62,000 | $43,000 |
| Net Non Operating Interest Income Expense | $1,009,000 | $1,216,000 | $723,000 | $-792,000 |
| Interest Expense Non Operating | $1,289,000 | $798,000 | $2,000 | $767,000 |
| Operating Expense | $22,941,000 | $21,538,000 | $22,289,000 | $14,930,000 |
| Other Operating Expenses | $6,051,000 | $4,597,000 | $1,790,000 | $570,000 |
| Total Other Finance Cost | - | $134,000 | $13,000 | $26,000 |
| Selling And Marketing Expense | - | $787,000 | $934,000 | $968,000 |
| General And Administrative Expense | - | $1,718,000 | $2,469,000 | $1,358,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Net Interest Income | $1,009,000 | $1,216,000 | $723,000 | $-792,000 |
| Interest Income | $2,298,000 | $2,014,000 | $738,000 | $1,000 |
| Normalized Income | $-18,461,000 | $-17,463,000 | $-18,273,400 | $-14,036,153 |
| Net Income From Continuing And Discontinued Operation | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Total Operating Income As Reported | $-19,417,000 | $-18,592,000 | $-18,524,000 | $-13,634,000 |
| Net Income Common Stockholders | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Net Income | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Net Income Including Noncontrolling Interests | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Net Income Continuous Operations | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Pretax Income | $-18,408,000 | $-17,375,000 | $-18,074,000 | $-16,194,000 |
| Interest Income Non Operating | $2,298,000 | $2,014,000 | $738,000 | $1,000 |
| Operating Income | $-19,403,000 | $-18,642,000 | $-18,697,000 | $-13,654,000 |
| Depreciation And Amortization In Income Statement | $8,294,000 | $8,158,000 | $6,689,000 | $4,245,000 |
| Depreciation Income Statement | $8,294,000 | $8,158,000 | $1,817,000 | $1,774,000 |
| Gross Profit | $3,538,000 | $2,896,000 | $3,592,000 | $1,276,000 |
| Special Income Charges | - | $0 | $144,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-0.31 | $-0.29 | $-0.30 | $-0.27 |
| Basic EPS | $-0.31 | $-0.29 | $-0.30 | $-0.27 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $47,600 | $-13,153 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,825,000 | $-8,419,000 | $-11,621,000 | $-9,114,000 |
| Reconciled Depreciation | $8,294,000 | $8,158,000 | $6,689,000 | $4,245,000 |
| EBITDA (Bullshit earnings) | $-8,825,000 | $-8,419,000 | $-11,383,000 | $-11,182,000 |
| EBIT | $-17,119,000 | $-16,577,000 | $-18,072,000 | $-15,427,000 |
| Diluted Average Shares | $60,923,908 | $60,918,459 | $60,341,000 | $60,239,000 |
| Basic Average Shares | $60,923,908 | $60,918,459 | $60,341,000 | $60,239,000 |
| Diluted NI Availto Com Stockholders | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Tax Provision | $53,000 | $88,000 | $9,000 | $-103,000 |
| Total Unusual Items | - | $0 | $238,000 | $-2,068,000 |
| Total Unusual Items Excluding Goodwill | - | $0 | $238,000 | $-2,068,000 |
| Amortization | - | $6,138,000 | $4,872,000 | $2,471,000 |
| Research And Development | - | $213,000 | $596,000 | $1,225,000 |
| Selling General And Administration | - | $2,505,000 | $3,403,000 | $2,326,000 |
| Other Special Charges | - | - | $-144,000 | - |
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $56,866,000 | $69,554,000 | $80,295,000 | $94,168,000 |
| Total Assets | $74,513,000 | $90,840,000 | $106,793,000 | $124,048,000 |
| Total Non Current Assets | $19,890,000 | $22,402,000 | $24,780,000 | $26,776,000 |
| Other Non Current Assets | $469,000 | $432,000 | $432,000 | $421,000 |
| Non Current Deferred Taxes Assets | $21,000 | $7,000 | $0 | - |
| Goodwill And Other Intangible Assets | $9,300,000 | $13,327,000 | $17,061,000 | $17,272,000 |
| Other Intangible Assets | $8,277,000 | $12,304,000 | $16,038,000 | $16,249,000 |
| Current Assets | $54,620,000 | $68,435,000 | $82,013,000 | $97,271,000 |
| Inventory | $1,742,000 | $704,000 | $550,000 | $591,000 |
| Accounts Receivable | $1,673,000 | $524,000 | $207,000 | $138,000 |
| Cash Cash Equivalents And Short Term Investments | $51,205,000 | $66,036,000 | $80,640,000 | $95,279,000 |
| Cash And Cash Equivalents | $41,288,000 | $43,651,000 | $80,640,000 | $95,279,000 |
| Prepaid Assets | - | $268,000 | $186,000 | $288,000 |
| Other Receivables | - | $903,000 | $430,000 | $975,000 |
| Investmentin Financial Assets | - | - | $0 | $1,206,000 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | - | - | $0 | $1,206,000 |
| Debt | ||||
| Total Debt | $3,566,000 | $2,637,000 | $5,031,000 | $7,883,000 |
| Long Term Debt And Capital Lease Obligation | $2,121,000 | $985,000 | $2,682,000 | $4,688,000 |
| Long Term Debt | $0 | $261,000 | $1,276,000 | $2,631,000 |
| Current Debt And Capital Lease Obligation | $1,445,000 | $1,652,000 | $2,349,000 | $3,195,000 |
| Current Debt | $261,000 | $566,000 | $1,384,000 | $2,073,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $8,347,000 | $7,959,000 | $9,437,000 | $12,608,000 |
| Total Non Current Liabilities Net Minority Interest | $2,141,000 | $1,007,000 | $2,680,000 | $4,687,000 |
| Other Non Current Liabilities | $-1,000 | $-2,000 | $-2,000 | $-1,000 |
| Non Current Deferred Taxes Liabilities | $21,000 | $24,000 | - | - |
| Current Liabilities | $6,206,000 | $6,952,000 | $6,757,000 | $7,921,000 |
| Other Current Liabilities | $826,000 | $100,000 | $101,000 | $101,000 |
| Payables | $3,935,000 | $4,279,000 | $3,388,000 | $3,424,000 |
| Accounts Payable | $3,935,000 | $1,301,000 | $1,059,000 | $1,118,000 |
| Other Payable | - | $2,978,000 | $2,329,000 | $2,306,000 |
| Total Tax Payable | - | - | - | $360,000 |
| Equity | ||||
| Common Stock Equity | $66,166,000 | $82,881,000 | $97,356,000 | $111,440,000 |
| Total Equity Gross Minority Interest | $66,166,000 | $82,881,000 | $97,356,000 | $111,440,000 |
| Stockholders Equity | $66,166,000 | $82,881,000 | $97,356,000 | $111,440,000 |
| Retained Earnings | $-76,494,000 | $-59,725,000 | $-45,194,000 | $-31,061,000 |
| Long Term Equity Investment | $1,000 | $37,000 | $69,000 | $102,000 |
| Investments In Other Ventures Under Equity Method | - | - | - | - |
| Other | ||||
| Treasury Shares Number | $577,920 | $577,920 | $577,920 | $577,920 |
| Ordinary Shares Number | $60,360,995 | $60,340,539 | $60,340,539 | $60,340,539 |
| Share Issued | $60,938,915 | $60,918,459 | $60,340,539 | $60,918,459 |
| Tangible Book Value | $56,866,000 | $69,554,000 | $80,295,000 | $94,168,000 |
| Invested Capital | $66,427,000 | $83,708,000 | $100,016,000 | $116,144,000 |
| Working Capital | $48,414,000 | $61,483,000 | $75,256,000 | $89,350,000 |
| Capital Lease Obligations | $3,305,000 | $1,810,000 | $2,371,000 | $3,179,000 |
| Total Capitalization | $66,166,000 | $83,142,000 | $98,632,000 | $114,071,000 |
| Capital Stock | $80,000 | $80,000 | $80,000 | $80,000 |
| Common Stock | $80,000 | $80,000 | $80,000 | $80,000 |
| Long Term Capital Lease Obligation | $2,121,000 | $724,000 | $1,406,000 | $2,057,000 |
| Current Capital Lease Obligation | $1,184,000 | $1,086,000 | $965,000 | $1,122,000 |
| Investmentsin Joint Venturesat Cost | $1,000 | $37,000 | $69,000 | $102,000 |
| Goodwill | $1,023,000 | $1,023,000 | $1,023,000 | $1,023,000 |
| Net PPE | $10,099,000 | $8,599,000 | $7,218,000 | $7,775,000 |
| Accumulated Depreciation | $-9,305,000 | $-7,000,000 | $-5,103,000 | $-683,000 |
| Gross PPE | $19,404,000 | $15,599,000 | $12,321,000 | $8,458,000 |
| Other Properties | $8,575,000 | $945,000 | $1,574,000 | $1,496,000 |
| Machinery Furniture Equipment | $10,049,000 | $8,637,000 | $5,400,000 | $3,979,000 |
| Buildings And Improvements | $780,000 | $6,017,000 | $5,347,000 | $2,983,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $9,917,000 | $22,385,000 | - | - |
| Raw Materials | - | $704,000 | $550,000 | $591,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $1,904,000 | $1,705,000 |
| Held To Maturity Securities | - | - | - | $1,206,000 |
| Available For Sale Securities | - | - | - | $421,000 |
| Current Provisions | - | - | - | - |
| Investmentsin Associatesat Cost | - | - | - | - |
| Finished Goods | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-14,262,000 | $-12,996,000 | $-11,743,000 | $-15,087,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,108,000 | $-8,408,000 | $-7,329,000 | $-7,474,000 |
| Investing Activities | ||||
| Capital Expenditure | $-4,154,000 | $-4,588,000 | $-4,414,000 | $-7,613,000 |
| Investing Cash Flow | $9,465,000 | $-25,536,000 | $-4,414,000 | $-8,323,000 |
| Capital Expenditure Reported | - | - | $-3,581,000 | $-6,240,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Financing Cash Flow | $-1,584,000 | $-2,826,000 | $-2,579,000 | $-2,863,000 |
| Net Other Financing Charges | $33,000 | $1,000 | $725,000 | $471,000 |
| Repurchase Of Capital Stock | - | - | - | $0 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Net Common Stock Issuance | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-296,000 | $-1,114,000 | $-1,531,000 | $-1,860,000 |
| End Cash Position | $41,288,000 | $43,651,000 | $80,640,000 | $95,279,000 |
| Other Cash Adjustment Outside Changein Cash | $1,000 | $-1,000 | $1,000 | - |
| Beginning Cash Position | $43,651,000 | $80,640,000 | $95,279,000 | $113,807,000 |
| Effect Of Exchange Rate Changes | $-137,000 | $-218,000 | $-318,000 | $132,000 |
| Changes In Cash | $-2,227,000 | $-36,770,000 | $-14,322,000 | $-18,660,000 |
| Net Issuance Payments Of Debt | $-296,000 | $-1,114,000 | $-1,531,000 | $-1,860,000 |
| Net Long Term Debt Issuance | $-296,000 | $-1,114,000 | $-1,531,000 | $-1,860,000 |
| Long Term Debt Payments | $-296,000 | $-1,114,000 | $-1,531,000 | $-1,860,000 |
| Interest Received Cfi | $1,125,000 | $1,372,000 | $0 | - |
| Net Investment Purchase And Sale | $12,466,000 | $-22,385,000 | $0 | $0 |
| Sale Of Investment | $71,140,000 | $69,000,000 | - | - |
| Purchase Of Investment | $-58,674,000 | $-91,385,000 | - | $0 |
| Net Business Purchase And Sale | $0 | $37,000 | $0 | $-710,000 |
| Sale Of Business | $0 | $37,000 | $0 | - |
| Net Intangibles Purchase And Sale | $-1,877,000 | $-2,379,000 | $-3,581,000 | - |
| Purchase Of Intangibles | $-1,877,000 | $-2,379,000 | $-3,581,000 | - |
| Net PPE Purchase And Sale | $-2,277,000 | $-2,209,000 | $-833,000 | $-1,373,000 |
| Purchase Of PPE | $-2,277,000 | $-2,209,000 | $-833,000 | $-1,373,000 |
| Taxes Refund Paid | $-46,000 | $-107,000 | $-7,000 | $-4,000 |
| Interest Received Cfo | $256,000 | $5,000 | $736,000 | $0 |
| Interest Paid Cfo | $-108,000 | $-175,000 | $-202,000 | $-822,000 |
| Change In Working Capital | $-991,000 | $-616,000 | $259,000 | $-807,000 |
| Change In Other Current Liabilities | $197,000 | $56,000 | $368,000 | $-325,000 |
| Change In Inventory | $-1,038,000 | $-154,000 | $42,000 | $67,000 |
| Change In Receivables | $-150,000 | $-518,000 | $-151,000 | $-549,000 |
| Other Non Cash Items | $-853,000 | $-1,262,000 | $-618,000 | $493,000 |
| Stock Based Compensation | $1,693,000 | $2,932,000 | $3,950,000 | $3,526,000 |
| Deferred Tax | $72,000 | $88,000 | $9,000 | $-103,000 |
| Depreciation And Amortization | $8,294,000 | $8,158,000 | $6,689,000 | $4,245,000 |
| Depreciation | $8,294,000 | $8,158,000 | $1,818,000 | $1,774,000 |
| Net Income From Continuing Operations | $-18,461,000 | $-17,463,000 | $-18,083,000 | $-16,091,000 |
| Amortization Cash Flow | - | $6,137,000 | $4,871,000 | $2,471,000 |
| Purchase Of Business | - | - | $0 | $-710,000 |
| Gain Loss On Investment Securities | - | - | $-94,000 | $2,067,000 |
| Issuance Of Debt | - | - | - | $0 |
| Common Stock Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Sale Of PPE | - | - | - | - |
| Change In Payable | - | - | - | - |